- Report
- August 2025
- 192 Pages
Global
From €3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 185 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- August 2025
- 199 Pages
Global
From €3147EUR$3,545USD£2,708GBP
€3496EUR$3,939USD£3,009GBP
- Report
- March 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- July 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- May 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- May 2025
- 175 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Report
- February 2025
- 200 Pages
Global
From €3985EUR$4,490USD£3,430GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1331EUR$1,500USD£1,146GBP
- Report
- June 2025
- 185 Pages
Global
From €3994EUR$4,500USD£3,438GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2476EUR$2,789USD£2,131GBP
- Report
- May 2024
- 137 Pages
Global
From €5769EUR$6,499USD£4,965GBP
- Report
- May 2024
- 138 Pages
Global
From €5769EUR$6,499USD£4,965GBP
- Report
- May 2023
- 103 Pages
Global
From €3500EUR$4,224USD£3,118GBP

Risedronate is a medication used to treat and prevent osteoporosis, a condition characterized by weak and brittle bones. It belongs to a class of drugs known as bisphosphonates, which work by slowing down the rate of bone breakdown and increasing bone density. Risedronate is also used to treat Paget's disease of bone, a disorder that causes abnormal bone growth and pain. It is available in both oral and intravenous forms.
Risedronate is a widely used drug in the Endocrine and Metabolic Disorders Drugs market. It is used to treat and prevent osteoporosis, a condition that affects millions of people worldwide. It is also used to treat Paget's disease of bone, a rare disorder that causes abnormal bone growth and pain. Risedronate is generally well-tolerated and has few side effects.
Some companies in the Risedronate market include Merck & Co., Inc., Teva Pharmaceuticals, and Mylan N.V. These companies manufacture and distribute the drug in various forms, including tablets, capsules, and injections. Show Less Read more